About Community Pharmacy South Central
Continuously improving the quality of care we give patients and
improving the outcomes of their treatment is the core purpose of
the new NHS commissioning system.
The latest news
Information on training events and resources available for you and your team
Written by admin on Wednesday 18th October 2017
Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly
Sildenafil 50 mg film-coated tablets were reclassified from a prescription only medicine (POM) to a Pharmacy medicine (P) in November 2017, following a public MHRA consultation. The outcome of the con
A new defence around inadvertent dispensing errors has come into force today (16 April), creating a safer environment for patients.
After a long-running campaign from RPS and the pharmacy profession,
Commenting on the key outcomes from the Royal Pharmaceutical Society’s English Pharmacy Board meeting on 12 April, Board Chair Sandra Gidley said:
“Patient care was at the heart of the co
We are delighted to announce we have had a total of 24 nominations for this year’s National Pharmacy Board elections.
For the English Pharmacy Board Election we have received 14 nominations for
Our offices are now closed and will reopen on 3rd April 2018 at 9am.
We wish everyone a Happy Easter!
At the meeting held on 22nd March 2018, RPS Assembly agreed a number of significant amendments to the Society’s Regulations that will take effect from 8th June. Please see full details at How We
Responding to NHS Englandguidance published todayon over the counter items that should not routinely be prescribed in primary care, RPS English Pharmacy Board Chair Sandra Gidley said:
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Medical Device Alert for all T34 ambulatory syringe pumps, due to a risk of unintended pump shutdown and delay to treatment.
Residents in nursing homes in England receive twice as many antibiotics as those of the same age living in their own homes, potentially harming their health and contributing to the growing problem of
The Medicines and Healthcare Products Regulatory Agency (MHRA) have issued a company led recall for one batch of Mesna 100mg/ml solution.